Missouri City, TX, United States of America

Richard T Lewis

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 9 CIPO patents and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard T Lewis. Retrieved from https://idiyas.com/inventor/richard-t-lewis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 9 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 10.0

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

Houston, TX (US) (2017)
Missouri City, TX (US) (2019 - 2024)

Company Filing History:

12 out of 5,638

The University of Texas System

patents

Years Active: 2017-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565490 - Inhibitors of Receptor Interacting Protein Kinase I for the treatment of disease (2026-03-03),

2. 12286406 - Inhibitors of receptor interacting protein kinase I for the treatment of disease (2025-04-29),

3. 11958849 - GLS1 inhibitors for treating disease (2024-04-16),

4. 11753381 - Inhibitors of receptor interacting protein kinase I for the treatment of disease (2023-09-12),

5. 11718612 - Inhibitors of receptor interacting protein kinase I for the treatment of disease (2023-08-08),

6. 11370786 - GLS1 inhibitors for treating disease (2022-06-28),

7. 11173145 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase (2021-11-16),

8. 11046649 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase (2021-06-29),

9. 10899769 - Imidazopiperazinone inhibitors of transcription activating proteins (2021-01-26),

10. 10766892 - GLS1 inhibitors for treating disease (2020-09-08),

11. 10344025 - GLS1 inhibitors for treating disease (2019-07-09),

12. 9809588 - GLS1 inhibitors for treating disease (2017-11-07),

Title: The Inventor Profile of Richard T Lewis

Introduction:

Richard T Lewis, a distinguished inventor hailing from Missouri City, TX (US), has made significant contributions to the field of innovation with his creative and groundbreaking ideas.

Latest Patents:

Richard T Lewis holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to existing problems. His latest patents focus on cutting-edge technologies that aim to revolutionize the way we live and work.

Career Highlights:

Throughout his illustrious career, Richard T Lewis has demonstrated a keen eye for identifying gaps in the market and developing innovative solutions to address them. His passion for creating impactful inventions has led to numerous successful ventures and collaborations with industry leaders.

Collaborations:

Richard T Lewis has collaborated with top companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in the successful commercialization of his patented technologies.

Conclusion:

In conclusion, Richard T Lewis stands as a beacon of innovation in Missouri City, TX (US), inspiring aspiring inventors to push the boundaries of what is possible. His dedication to creating meaningful change through his inventions cements his legacy as a visionary in the world of innovation.

Profile summary based on public USPTO records.